We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Inflammation Reduction Trial
Updated: 4/3/2018
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Updated: 4/3/2018
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Status: Enrolling
Updated: 4/3/2018
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Updated: 4/3/2018
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Dietary Lipid Induced Insulin Resistance
Updated: 4/3/2018
Mechanisms of Dietary Lipid Induced Insulin Resistance
Status: Enrolling
Updated: 4/3/2018
Dietary Lipid Induced Insulin Resistance
Updated: 4/3/2018
Mechanisms of Dietary Lipid Induced Insulin Resistance
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption
Updated: 4/3/2018
Controlled Feeding Study to Show Effects of Manipulating Carbohydrate and Cheese on Health Markers In Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption
Updated: 4/3/2018
Controlled Feeding Study to Show Effects of Manipulating Carbohydrate and Cheese on Health Markers In Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
A Study of the Function of Hormones Present In Taste Buds
Updated: 4/4/2018
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated: 4/4/2018
A Study of the Function of Hormones Present In Taste Buds
Updated: 4/4/2018
A Study of the Function of Hormones Present In Taste Buds
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Evaluation of Albuminuria HIV-Infected Patients
Updated: 4/4/2018
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
Evaluation of Albuminuria HIV-Infected Patients
Updated: 4/4/2018
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Evaluation of Albuminuria HIV-Infected Patients
Updated: 4/4/2018
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
Evaluation of Albuminuria HIV-Infected Patients
Updated: 4/4/2018
Prospective Evaluation of Albuminuria in HIV Positive Patients
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Updated: 4/4/2018
Study of Molecular Pathways in Medullary Thyroid Carcinoma (MTC) and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Status: Enrolling
Updated: 4/4/2018
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Updated: 4/4/2018
Study of Molecular Pathways in Medullary Thyroid Carcinoma (MTC) and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Updated: 4/4/2018
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Updated: 4/4/2018
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Updated: 4/9/2018
A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Updated: 4/10/2018
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Status: Enrolling
Updated: 4/10/2018
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Updated: 4/10/2018
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Status: Enrolling
Updated: 4/10/2018
Click here to add this to my saved trials
Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
Updated: 4/11/2018
Comparison of Sleep-wake LH Frequency in Peripubertal Girls With and Without Hyperandrogenemia
Status: Enrolling
Updated: 4/11/2018
Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone
Updated: 4/11/2018
Comparison of Sleep-wake LH Frequency in Peripubertal Girls With and Without Hyperandrogenemia
Status: Enrolling
Updated: 4/11/2018
Click here to add this to my saved trials
Hypogonadism in Young Men With Type 2 Diabetes
Updated: 4/17/2018
Effect of Hypogonadotropic Hypogonadism and Replacement With Clomiphene Citrate and Testosterone on Insulin Sensitivity, Body Composition, Inflammation, Sexual Function and Spermatogenesis in Young Type 2 Diabetic Men
Status: Enrolling
Updated: 4/17/2018
Hypogonadism in Young Men With Type 2 Diabetes
Updated: 4/17/2018
Effect of Hypogonadotropic Hypogonadism and Replacement With Clomiphene Citrate and Testosterone on Insulin Sensitivity, Body Composition, Inflammation, Sexual Function and Spermatogenesis in Young Type 2 Diabetic Men
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Updated: 4/17/2018
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated: 4/17/2018
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Updated: 4/17/2018
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Updated: 4/17/2018
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Status: Enrolling
Updated: 4/17/2018
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Updated: 4/17/2018
Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
Status: Enrolling
Updated: 4/17/2018
Click here to add this to my saved trials
A Mobile Phone-based Program for Adults With Prediabetes
Updated: 4/18/2018
A Mixed Methods Pilot Randomized Controlled Trial of a Mobile Phone-based Health Program Among Adults With Prediabetes
Status: Enrolling
Updated: 4/18/2018
A Mobile Phone-based Program for Adults With Prediabetes
Updated: 4/18/2018
A Mixed Methods Pilot Randomized Controlled Trial of a Mobile Phone-based Health Program Among Adults With Prediabetes
Status: Enrolling
Updated: 4/18/2018
Click here to add this to my saved trials
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Updated: 4/19/2018
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Updated: 4/19/2018
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Updated: 4/19/2018
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Status: Enrolling
Updated: 4/19/2018
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Updated: 4/19/2018
Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Updated: 4/19/2018
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated: 4/19/2018
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Updated: 4/19/2018
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated: 4/19/2018
Click here to add this to my saved trials
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Updated: 4/27/2018
Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Status: Enrolling
Updated: 4/27/2018
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Updated: 4/27/2018
Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Status: Enrolling
Updated: 4/27/2018
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
Updated: 4/30/2018
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated: 4/30/2018
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
Updated: 4/30/2018
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated: 4/30/2018
Click here to add this to my saved trials